Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Research Report 2023

Oral Nonsteroidal Anti-Inflammatory Drugs Market

Nonsteroidal anti-inflammatory drugs (NSAIDs) are medicines that are commonly used for pain relief, stress reduction and high temperature control. They are often used to relieve symptoms of periods of pain, sprains and strains, headaches, cold and flu, arthritis and other long-term pain causes. Non-steroidal medications have sedative and anti-inflammatory effects. Inflammation is caused by the COX-1 and COX-2 enzymes which are inhibited by non-steroidal anti-inflammatory medications (NSAIDs). Some common examples of typical non-steroidal anti-inflammatory medications include aspirin, naproxen, ibuprofen, and paracetamol.

Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Nonsteroidal Anti-Inflammatory Drugs market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Oral Nonsteroidal Anti-Inflammatory Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Oral Nonsteroidal Anti-Inflammatory Drugs Market Report

1.1 Product Overview and Scope of Oral Nonsteroidal Anti-Inflammatory Drugs

1.2 Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Type

1.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2023-2029)

1.2.2 Penecillins

1.2.3 Cephalosporins

1.2.4 Tetracyclins

1.2.5 Sulfonamides

1.2.6 Other

1.3 Oral Nonsteroidal Anti-Inflammatory Drugs Segment by Application

1.3.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value by Application: (2023-2029)

1.3.2 Sterilization

1.3.3 Bacteriostasis

1.4 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size Estimates and Forecasts

1.4.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue 2018-2029

1.4.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales 2018-2029

1.4.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2018-2023)

2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Average Price by Manufacturers (2018-2023)

2.4 Global Oral Nonsteroidal Anti-Inflammatory Drugs Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs, Product Type & Application

2.7 Oral Nonsteroidal Anti-Inflammatory Drugs Market Competitive Situation and Trends

2.7.1 Oral Nonsteroidal Anti-Inflammatory Drugs Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Oral Nonsteroidal Anti-Inflammatory Drugs Players Market Share by Revenue

2.7.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region: 2018-2029

3.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region: 2018-2023

3.2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region: 2024-2029

3.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region: 2018-2029

3.3.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region: 2018-2023

3.3.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region: 2024-2029

3.4 North America Oral Nonsteroidal Anti-Inflammatory Drugs Market Facts & Figures by Country

3.4.1 North America Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2029)

3.4.3 North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Market Facts & Figures by Country

3.5.1 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2029)

3.5.3 Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Market Facts & Figures by Country

3.6.1 Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2029)

3.6.3 Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Market Facts & Figures by Country

3.7.1 Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2029)

3.7.3 Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Nonsteroidal Anti-Inflammatory Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2029)

3.8.3 Middle East and Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type (2018-2029)

4.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type (2018-2023)

4.1.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Type (2024-2029)

4.1.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Type (2018-2029)

4.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Type (2018-2029)

4.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Type (2018-2023)

4.2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Type (2024-2029)

4.2.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2018-2029)

4.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Price by Type (2018-2029)

5.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application (2018-2029)

5.1.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application (2018-2023)

5.1.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Application (2024-2029)

5.1.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Application (2018-2029)

5.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Application (2018-2029)

5.2.1 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Application (2018-2023)

5.2.2 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Application (2024-2029)

5.2.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2018-2029)

5.3 Global Oral Nonsteroidal Anti-Inflammatory Drugs Price by Application (2018-2029)

6.1 Bayer AG

6.1.1 Bayer AG Corporation Information

6.1.2 Bayer AG Description and Business Overview

6.1.3 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.1.5 Bayer AG Recent Developments/Updates

6.2 Pfizer Inc

6.2.1 Pfizer Inc Corporation Information

6.2.2 Pfizer Inc Description and Business Overview

6.2.3 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.2.5 Pfizer Inc Recent Developments/Updates

6.3 Reckitt Benckiser Group PLC

6.3.1 Reckitt Benckiser Group PLC Corporation Information

6.3.2 Reckitt Benckiser Group PLC Description and Business Overview

6.3.3 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.3.5 Reckitt Benckiser Group PLC Recent Developments/Updates

6.4 Novartis AG

6.4.1 Novartis AG Corporation Information

6.4.2 Novartis AG Description and Business Overview

6.4.3 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.4.5 Novartis AG Recent Developments/Updates

6.5 DAIICHI SANKYO COMPANY, LIMITED

6.5.1 DAIICHI SANKYO COMPANY, LIMITED Corporation Information

6.5.2 DAIICHI SANKYO COMPANY, LIMITED Description and Business Overview

6.5.3 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.5.4 DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.5.5 DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates

6.6 Zydus Group

6.6.1 Zydus Group Corporation Information

6.6.2 Zydus Group Description and Business Overview

6.6.3 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.6.5 Zydus Group Recent Developments/Updates

6.7 Lupin

6.6.1 Lupin Corporation Information

6.6.2 Lupin Description and Business Overview

6.6.3 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.7.5 Lupin Recent Developments/Updates

6.8 GSK Plc

6.8.1 GSK Plc Corporation Information

6.8.2 GSK Plc Description and Business Overview

6.8.3 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.8.4 GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.8.5 GSK Plc Recent Developments/Updates

6.9 Glenmark Pharmaceuticals Inc

6.9.1 Glenmark Pharmaceuticals Inc Corporation Information

6.9.2 Glenmark Pharmaceuticals Inc Description and Business Overview

6.9.3 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.9.4 Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.9.5 Glenmark Pharmaceuticals Inc Recent Developments/Updates

6.10 Amneal Pharmaceuticals

6.10.1 Amneal Pharmaceuticals Corporation Information

6.10.2 Amneal Pharmaceuticals Description and Business Overview

6.10.3 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.10.5 Amneal Pharmaceuticals Recent Developments/Updates

6.11 AstraZeneca

6.11.1 AstraZeneca Corporation Information

6.11.2 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Description and Business Overview

6.11.3 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.11.4 AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.11.5 AstraZeneca Recent Developments/Updates

6.12 Johnson & Johnson

6.12.1 Johnson & Johnson Corporation Information

6.12.2 Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Description and Business Overview

6.12.3 Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Sales, Revenue and Gross Margin (2018-2023)

6.12.4 Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Product Portfolio

6.12.5 Johnson & Johnson Recent Developments/Updates

7.1 Oral Nonsteroidal Anti-Inflammatory Drugs Industry Chain Analysis

7.2 Oral Nonsteroidal Anti-Inflammatory Drugs Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Nonsteroidal Anti-Inflammatory Drugs Production Mode & Process

7.4 Oral Nonsteroidal Anti-Inflammatory Drugs Sales and Marketing

7.4.1 Oral Nonsteroidal Anti-Inflammatory Drugs Sales Channels

7.4.2 Oral Nonsteroidal Anti-Inflammatory Drugs Distributors

7.5 Oral Nonsteroidal Anti-Inflammatory Drugs Customers

8.1 Oral Nonsteroidal Anti-Inflammatory Drugs Industry Trends

8.2 Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers

8.3 Oral Nonsteroidal Anti-Inflammatory Drugs Market Challenges

8.4 Oral Nonsteroidal Anti-Inflammatory Drugs Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Oral Nonsteroidal Anti-Inflammatory Drugs Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Oral Nonsteroidal Anti-Inflammatory Drugs, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs, Product Type & Application

    Table 12. Global Key Manufacturers of Oral Nonsteroidal Anti-Inflammatory Drugs, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Oral Nonsteroidal Anti-Inflammatory Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Nonsteroidal Anti-Inflammatory Drugs as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region (2018-2023) & (K Units)

    Table 18. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Region (2018-2023)

    Table 19. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region (2024-2029) & (K Units)

    Table 20. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Region (2024-2029)

    Table 21. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2023)

    Table 23. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2024-2029)

    Table 25. North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2023) & (K Units)

    Table 27. North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2024-2029) & (K Units)

    Table 28. North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units) by Type (2018-2023)

    Table 51. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units) by Type (2024-2029)

    Table 52. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Type (2018-2023)

    Table 53. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Type (2024-2029)

    Table 54. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2018-2023)

    Table 57. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Type (2024-2029)

    Table 58. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units) by Application (2018-2023)

    Table 61. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units) by Application (2024-2029)

    Table 62. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Application (2018-2023)

    Table 63. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Application (2024-2029)

    Table 64. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2018-2023)

    Table 67. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Application (2024-2029)

    Table 68. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2024-2029)

    Table 70. Bayer AG Corporation Information

    Table 71. Bayer AG Description and Business Overview

    Table 72. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Bayer AG Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 74. Bayer AG Recent Developments/Updates

    Table 75. Pfizer Inc Corporation Information

    Table 76. Pfizer Inc Description and Business Overview

    Table 77. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Pfizer Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 79. Pfizer Inc Recent Developments/Updates

    Table 80. Reckitt Benckiser Group PLC Corporation Information

    Table 81. Reckitt Benckiser Group PLC Description and Business Overview

    Table 82. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Reckitt Benckiser Group PLC Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 84. Reckitt Benckiser Group PLC Recent Developments/Updates

    Table 85. Novartis AG Corporation Information

    Table 86. Novartis AG Description and Business Overview

    Table 87. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Novartis AG Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 89. Novartis AG Recent Developments/Updates

    Table 90. DAIICHI SANKYO COMPANY, LIMITED Corporation Information

    Table 91. DAIICHI SANKYO COMPANY, LIMITED Description and Business Overview

    Table 92. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. DAIICHI SANKYO COMPANY, LIMITED Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 94. DAIICHI SANKYO COMPANY, LIMITED Recent Developments/Updates

    Table 95. Zydus Group Corporation Information

    Table 96. Zydus Group Description and Business Overview

    Table 97. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. Zydus Group Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 99. Zydus Group Recent Developments/Updates

    Table 100. Lupin Corporation Information

    Table 101. Lupin Description and Business Overview

    Table 102. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Lupin Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 104. Lupin Recent Developments/Updates

    Table 105. GSK Plc Corporation Information

    Table 106. GSK Plc Description and Business Overview

    Table 107. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. GSK Plc Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 109. GSK Plc Recent Developments/Updates

    Table 110. Glenmark Pharmaceuticals Inc Corporation Information

    Table 111. Glenmark Pharmaceuticals Inc Description and Business Overview

    Table 112. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 113. Glenmark Pharmaceuticals Inc Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 114. Glenmark Pharmaceuticals Inc Recent Developments/Updates

    Table 115. Amneal Pharmaceuticals Corporation Information

    Table 116. Amneal Pharmaceuticals Description and Business Overview

    Table 117. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 118. Amneal Pharmaceuticals Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 119. Amneal Pharmaceuticals Recent Developments/Updates

    Table 120. AstraZeneca Corporation Information

    Table 121. AstraZeneca Description and Business Overview

    Table 122. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 123. AstraZeneca Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 124. AstraZeneca Recent Developments/Updates

    Table 125. Johnson & Johnson Corporation Information

    Table 126. Johnson & Johnson Description and Business Overview

    Table 127. Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 128. Johnson & Johnson Oral Nonsteroidal Anti-Inflammatory Drugs Product

    Table 129. Johnson & Johnson Recent Developments/Updates

    Table 130. Key Raw Materials Lists

    Table 131. Raw Materials Key Suppliers Lists

    Table 132. Oral Nonsteroidal Anti-Inflammatory Drugs Distributors List

    Table 133. Oral Nonsteroidal Anti-Inflammatory Drugs Customers List

    Table 134. Oral Nonsteroidal Anti-Inflammatory Drugs Market Trends

    Table 135. Oral Nonsteroidal Anti-Inflammatory Drugs Market Drivers

    Table 136. Oral Nonsteroidal Anti-Inflammatory Drugs Market Challenges

    Table 137. Oral Nonsteroidal Anti-Inflammatory Drugs Market Restraints

    Table 138. Research Programs/Design for This Report

    Table 139. Key Data Information from Secondary Sources

    Table 140. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Oral Nonsteroidal Anti-Inflammatory Drugs

    Figure 2. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Share by Type in 2022 & 2029

    Figure 4. Penecillins Product Picture

    Figure 5. Cephalosporins Product Picture

    Figure 6. Tetracyclins Product Picture

    Figure 7. Sulfonamides Product Picture

    Figure 8. Other Product Picture

    Figure 9. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 10. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Share by Application in 2022 & 2029

    Figure 11. Sterilization

    Figure 12. Bacteriostasis

    Figure 13. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Oral Nonsteroidal Anti-Inflammatory Drugs Sales (2018-2029) & (K Units)

    Figure 16. Global Oral Nonsteroidal Anti-Inflammatory Drugs Average Price (US$/Unit) & (2018-2029)

    Figure 17. Oral Nonsteroidal Anti-Inflammatory Drugs Report Years Considered

    Figure 18. Oral Nonsteroidal Anti-Inflammatory Drugs Sales Share by Manufacturers in 2022

    Figure 19. Global Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Oral Nonsteroidal Anti-Inflammatory Drugs Players: Market Share by Revenue in 2022

    Figure 21. Oral Nonsteroidal Anti-Inflammatory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Oral Nonsteroidal Anti-Inflammatory Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Country (2018-2029)

    Figure 24. North America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2018-2029)

    Figure 25. United States Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Country (2018-2029)

    Figure 28. Europe Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Region (2018-2029)

    Figure 36. China Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Southeast Asia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Country (2018-2029)

    Figure 44. Latin America Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2018-2029)

    Figure 45. Mexico Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Brazil Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Argentina Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Sales Market Share by Country (2018-2029)

    Figure 49. Middle East & Africa Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Market Share by Country (2018-2029)

    Figure 50. Turkey Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Saudi Arabia Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. UAE Oral Nonsteroidal Anti-Inflammatory Drugs Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Global Sales Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs by Type (2018-2029)

    Figure 54. Global Revenue Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs by Type (2018-2029)

    Figure 55. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Type (2018-2029)

    Figure 56. Global Sales Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs by Application (2018-2029)

    Figure 57. Global Revenue Market Share of Oral Nonsteroidal Anti-Inflammatory Drugs by Application (2018-2029)

    Figure 58. Global Oral Nonsteroidal Anti-Inflammatory Drugs Price (US$/Unit) by Application (2018-2029)

    Figure 59. Oral Nonsteroidal Anti-Inflammatory Drugs Value Chain

    Figure 60. Oral Nonsteroidal Anti-Inflammatory Drugs Production Process

    Figure 61. Channels of Distribution (Direct Vs Distribution)

    Figure 62. Distributors Profiles

    Figure 63. Bottom-up and Top-down Approaches for This Report

    Figure 64. Data Triangulation

    Figure 65. Key Executives Interviewed